MedTrace Logo

Evaluation of Oral Collagen Peptides on Skin Barrier Function in Women

NCT07529249 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2026-05-12

No results posted yet for this study

Summary

This clinical study aims to determine whether taking two different doses of collagen-derived peptides for three months improves facial skin barrier integrity in women with dry, sensitive skin, compared with a placebo.

Conditions

  • Dry Skin
  • Sensitive Skin
  • Dry Skin in the Elderly
  • Dietary Supplement

Interventions

DIETARY_SUPPLEMENT

Investigational Product 1

This product is going to be concentrated at 2000mg

DIETARY_SUPPLEMENT

Investigational Product 2

This product is going to be concentrated at 5000mg

DIETARY_SUPPLEMENT

Placebo

This product is going to be flavoured water

Sponsors & Collaborators

  • Rousselot BVBA

    collaborator INDUSTRY

  • Centre de Pharmacologie Clinique Applique a la Dermatologie

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2026-08-31
Completion
2026-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07529249 on ClinicalTrials.gov